Diabetes drug may fight inflammation after stent procedure
Knowledge-focused
Recruiting now
This study tests whether empagliflozin, a diabetes drug known to help heart failure patients, can also reduce inflammation after a heart stent procedure. About 100 people with stable coronary artery disease scheduled for a stent will take either empagliflozin or a placebo for thr…
Phase: PHASE4 • Sponsor: Hotel Dieu de France Hospital • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC